Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
QUEST DIAGNOSTICS INC | SVP, Advanced Diagnostics | Common Stock | 48.4K | $5.95M | $122.86 | Mar 7, 2022 | Direct |
ORASURE TECHNOLOGIES INC | President & CEO, Director | Common Stock | 1.18M | $5.49M | $4.65 | Jun 4, 2024 | Direct |
QUEST DIAGNOSTICS INC | SVP, Advanced Diagnostics | Non-Qualifed Stock Option (right to buy) | 19K | $1.65M | $86.63 | Feb 24, 2022 | Direct |
REPLIGEN CORP | Director | Common Stock | 3.49K | $571K | $163.34 | May 16, 2024 | Direct |
REPLIGEN CORP | Director | Stock Option (Right to Buy) | 1.38K | May 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OSUR | ORASURE TECHNOLOGIES INC | Jun 4, 2024 | 1 | -$1.87M | 4 | Jun 6, 2024 | President & CEO, Director |
RGEN | REPLIGEN CORP | May 16, 2024 | 2 | $0 | 4 | May 20, 2024 | Director |
OSUR | ORASURE TECHNOLOGIES INC | Mar 1, 2024 | 2 | -$213K | 4 | Mar 5, 2024 | President & CEO, Director |
OSUR | ORASURE TECHNOLOGIES INC | Jun 4, 2023 | 1 | -$259K | 4 | Jun 6, 2023 | President & CEO, Director |
RGEN | REPLIGEN CORP | May 18, 2023 | 0 | $0 | 4/A | Dec 15, 2023 | Director |
OSUR | ORASURE TECHNOLOGIES INC | Mar 1, 2023 | 1 | $0 | 4 | Mar 3, 2023 | President & CEO, Director |
OSUR | ORASURE TECHNOLOGIES INC | Jun 4, 2022 | 2 | $5.6M | 4 | Jun 6, 2022 | President & CEO, Director |
OSUR | ORASURE TECHNOLOGIES INC | Jun 4, 2022 | 0 | $0 | 3 | Jun 6, 2022 | President & CEO, Director |
RGEN | REPLIGEN CORP | May 26, 2022 | 2 | $0 | 4 | May 31, 2022 | Director |
RGEN | REPLIGEN CORP | Mar 16, 2022 | 1 | $109K | 4 | Dec 15, 2022 | Director |
DGX | QUEST DIAGNOSTICS INC | Mar 7, 2022 | 2 | $1.07M | 4 | Mar 9, 2022 | SVP, Advanced Diagnostics |
DGX | QUEST DIAGNOSTICS INC | Feb 24, 2022 | 3 | $0 | 4 | Feb 28, 2022 | SVP, Advanced Diagnostics |
DGX | QUEST DIAGNOSTICS INC | Feb 23, 2022 | 2 | -$257K | 4 | Feb 25, 2022 | SVP, Advanced Diagnostics |
RGEN | REPLIGEN CORP | May 13, 2021 | 2 | $0 | 4 | May 17, 2021 | Director |